Skip to main content

Daniel H. Follansbee

Member

[email protected]

+1.617.348.4474

Share:

Daniel is a skilled corporate and transactional lawyer who regularly represents technology-based companies, principally in the areas of biotechnology, medical technologies, healthcare IT, and other technology sectors. He routinely counsels these clients on many aspects of their corporate development, from initial organization and acquisition of technology, through private and public financings, to strategic alliances and business combination transactions. Having previously served in-house at a technology company, Daniel is deeply conversant with the legal needs of companies at different stages of their life cycle.

Daniel’s practice involves all aspects of corporate and transactional law and general business representation, including mergers and acquisitions; equity, debt, and convertible debt financings; and general business counseling. He represents both public and private US companies in a wide variety of industries on an ongoing basis. He also represents foreign companies with respect to US acquisitions and securities laws.

Daniel has overseen EB-5 offerings for clients across various sectors, with particular experience in the transactional, corporate, and securities compliance components of EB-5 transactions. Daniel also counsels clients on the full range of securities laws and regulations that impact EB-5 offerings, with particular attention to Regulation S and D compliance. With a robust background in corporate and securities law, Daniel works with clients in the EB-5 space to make deals happen while assisting those clients with securities law compliance.

Before joining the firm, Daniel served as associate general counsel for a public information technology company and its public and private controlled subsidiaries. There, he negotiated and advised management with respect to mergers, acquisitions, share exchanges, and private placements. He also advised the board of directors on corporate governance matters. He previously worked in the corporate section of another large Boston law firm, primarily representing clients in the technology industries.

While attending law school, Daniel served as a summer law clerk at the Office of the US Trustee of the US Department of Justice. There, he reviewed Chapter 11 petitions, debtor monthly operating reports, disclosure statements, and plans of reorganization.

Daniel is a skilled corporate and transactional lawyer who regularly represents technology-based companies, principally in the areas of biotechnology, medical technologies, healthcare IT, and other technology sectors. He routinely counsels these clients on many aspects of their corporate development, from initial organization and acquisition of technology, through private and public financings, to strategic alliances and business combination transactions. Having previously served in-house at a technology company, Daniel is deeply conversant with the legal needs of companies at different stages of their life cycle.

Experience

Mergers & Acquisitions

  • Represented QIAGEN N.V. in the $260M acquisition of the digital pcr assets of Formulatrix, Inc.
  • Represented QIAGEN N.V. in its $234M strategic partnership with NeuMoDx Molecular, Inc. 
  • Represented Dassault Systèmes in its $425M acquisition of IQMS, Inc.
  • Represented Dassault Systèmes in its acquisition of No Magic, Incorporated

Venture Capital

  • Represented Mitra RxDx (dba Mitra Biotech) in its $40M financing led by Northpond Ventures, and included Accel, Sequoia Capital, Sands Capital Ventures, and RA Capital Management 
  • Represented Endotronix, Inc. in its $40M Series D financing led by LSP, investing from its LSP Health Economics Fund 2, and included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments, and an unnamed corporate strategic investor
Read less

News & Press

Press Release Thumbnail
Mintz is representing Future Electronics in its announced sale to Taiwan-based WT Microelectronics (TAIEX: 3036). The all-cash sale will see WT Microelectronics acquire 100% of Future Electronics shares for an enterprise value of $3.8 billion. The transaction is expected to close in the first half of 2024.
Mintz attorneys represented Seventh Generation, Inc. in its recent sale to Unilever. Based in Vermont, Seventh Generation is a pioneer in corporate responsibility and sustainable product innovations, including plant-based detergents and household cleaners.
Daniel Follansbee is featured in these videos, covering Series A financing, with topics ranging from choosing and creating business entities to receiving financing and liquidity.
The 2015 Chambers USA: America's Leading Lawyers for Business guide names 52 Mintz, Cohn, Ferris, Glovsky and Popeo, P.C.  attorneys as “Leaders in Their Fields.”
Read less

Events & Speaking

Speaker
Jun
23
2016

Getting Savvy on Series A Financings

Venture Café

Cambridge, MA

Read less

Daniel is a skilled corporate and transactional lawyer who regularly represents technology-based companies, principally in the areas of biotechnology, medical technologies, healthcare IT, and other technology sectors. He routinely counsels these clients on many aspects of their corporate development, from initial organization and acquisition of technology, through private and public financings, to strategic alliances and business combination transactions. Having previously served in-house at a technology company, Daniel is deeply conversant with the legal needs of companies at different stages of their life cycle.

Recognition & Awards

  • Chambers USA: Massachusetts (Up and Coming) – Corporate/M&A (2013 – 2015)

Read less

Daniel is a skilled corporate and transactional lawyer who regularly represents technology-based companies, principally in the areas of biotechnology, medical technologies, healthcare IT, and other technology sectors. He routinely counsels these clients on many aspects of their corporate development, from initial organization and acquisition of technology, through private and public financings, to strategic alliances and business combination transactions. Having previously served in-house at a technology company, Daniel is deeply conversant with the legal needs of companies at different stages of their life cycle.

Involvement

  • Member, Massachusetts Bar Association
  • Member, Boston Bar Associations
Read less